Patient of the Month: Mateo


Published on: 09/04/2018

When Mateo was just two years old, his parents were shocked to discover that their toddler developed leukemia. They met with the hematology and oncology specialists at Nicklaus Children’s Hospital and began a treatment protocol that brought Mateo back to health—along with some entertainment from his spirited little sister! Mateo, now 10, is a healthy, typical kid who loves running around with his friends.

Read Previous Read Next

Related News

Abbey's Strength and Spirit Shine Through as she Battles Leukemia

September 15, 2026 –

Abbey was initially diagnosed with a viral infection, but a second opinion at Nicklaus Children’s Hospital revealed she had T-cell acute lymphoblastic leukemia and needed immediate treatment. Nearly a year later, she is in the maintenance phase and back to enjoying first grade, tennis, and pranking her parents.


Patient of the Month: Megan

January 26, 2026 – At only seven years old, Megan underwent aggressive cancer treatment that included infusions and chemotherapy and lasted about two years.

Incredible Advances in Cancer Treatment Through Research

September 16, 2025 – In recognition of Pediatric Cancer Awareness Month, this issue of the Research Rundown is dedicated to the incredible advances in cancer treatment through research. The Nicklaus Children's Research Institute (NCRI) with the Helen & Jacob Shaham Cancer & Blood Disorders Institute have more than 30 studies that are actively recruiting new subjects.

Helen & Jacob Shaham Cancer & Blood Disorders Institute at Nicklaus Children's Hospital Recognized for Excellence in Cancer Registration

August 28, 2025 – The Florida Department of Health and the Florida Cancer Data System (FCDS) has awarded the Helen & Jacob Shaham Cancer & Blood Disorders Institute at Nicklaus Children's Hospital the 2024 Jean Byers Memorial Award for Excellence in Cancer Registration. The FCDS recognizes facilities that have met or exceeded the national quality standards for timeliness and completeness in cancer reporting.